arrow
S

Steven D. Nathan

Inova Schar Heart and Vascular Institute
H指数:74
被引数:2.4万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Clinical Characteristics and Outcomes of Anti-MDA5 Antibody-Associated Interstitial Lung Disease: A Single-Center Retrospective Cohort Study from an Integrated Advanced Lung Disease and Lung Transplant Program in the US

抗MDA5抗体相关性间质性肺疾病的临床特征与结局:一项来自美国综合先进肺病与肺移植项目单中心的回顾性队列研究

2026-10-010
OA
Association of CD16hiCD62Llo Neutrophils with Disease Severity and Impact of SYK Inhibition in Sepsis

CD16<sup>hi</sup>CD62L<sup>lo</sup>中性粒细胞与败血症严重程度的关系及SYK抑制的影响

2026-09-030
OA
Survival in patients with pulmonary hypertension associated with fibrotic interstitial lung disease (ILD) is independent of ILD subtype

特发性肺纤维化相关肺动脉高压患者的生存率与ILD亚型无关

2025-12-220
PRE
SARS-CoV-2 Immune Complex-Mediated Neutrophil Activation
2025-04-010
PRE
Molecular criteria for pulmonary antibody-mediated rejection are associated with an increased risk of allograft failure

分子标准用于肺抗体介导的排斥反应,与移植物衰竭风险增加相关。

2025-03-200
PRE
Preacinar Arterial Dilation Mediates Outcomes of Quantitative Interstitial Abnormalities in the COPDGene Study

前腺泡动脉扩张介导了COPDGene研究中定量间质异常的结果

2024-11-010
PRE
Plasma Adsorption with the MTx.100 Column in Critically Ill COVID-19 Patients: A Prospective Study and Propensity Score Analysis
2024-09-120
PRE
Extreme elevations of donor-derived cell-free DNA increases the risk of chronic lung allograft dysfunction and death, even without clinical manifestations of disease

供体来源的无细胞DNA的极端升高会增加慢性同种异体肺功能障碍和死亡的风险,即使没有疾病的临床表现

2024-09-011
PRE
Inhaled treprostinil in pulmonary hypertension associated with COPD: PERFECT study results
2024-05-294
OAAI